Cargando…

RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response

BACKGROUND: Challenges around the design and investigation of cell culture models of adamantinomatous craniopharyngioma (ACP) have arisen from the cellular heterogeneity of these tumors, with populations that harbor disparate requirements in culture. Novel approaches to in vitro modeling of ACP are...

Descripción completa

Detalles Bibliográficos
Autores principales: Trudeau, Tammy, Prince, Eric, Chatain, Oscar, Chee, Keanu, Jackson, Eric, Limbrick, David, Naftel, Robert, Feldstein, Neil, Grant, Gerald, Ginn, Kevin, Niazi, Toba, Smith, Amy, Kilburn, Lindsay, Chern, Joshua, Drapeau, Annie, Lam, Sandi, Johnston, James, Dudley, Roy, Staulcup, Susan, Hankinson, Todd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165211/
http://dx.doi.org/10.1093/neuonc/noac079.049
_version_ 1784720337898831872
author Trudeau, Tammy
Prince, Eric
Chatain, Oscar
Chee, Keanu
Jackson, Eric
Limbrick, David
Naftel, Robert
Feldstein, Neil
Grant, Gerald
Ginn, Kevin
Niazi, Toba
Smith, Amy
Kilburn, Lindsay
Chern, Joshua
Drapeau, Annie
Lam, Sandi
Johnston, James
Dudley, Roy
Staulcup, Susan
Hankinson, Todd
author_facet Trudeau, Tammy
Prince, Eric
Chatain, Oscar
Chee, Keanu
Jackson, Eric
Limbrick, David
Naftel, Robert
Feldstein, Neil
Grant, Gerald
Ginn, Kevin
Niazi, Toba
Smith, Amy
Kilburn, Lindsay
Chern, Joshua
Drapeau, Annie
Lam, Sandi
Johnston, James
Dudley, Roy
Staulcup, Susan
Hankinson, Todd
author_sort Trudeau, Tammy
collection PubMed
description BACKGROUND: Challenges around the design and investigation of cell culture models of adamantinomatous craniopharyngioma (ACP) have arisen from the cellular heterogeneity of these tumors, with populations that harbor disparate requirements in culture. Novel approaches to in vitro modeling of ACP are needed. METHODS: Intraoperatively collected tumor specimens were mechanically digested and plated under conditions tailored to the cell population of interest. ACP tumor-derived fibroblasts and epithelial cells were isolated using serum-containing and keratinocyte-specific media respectively. ACP-derived epithelial cells were immortalized via SV40 virus transfection and puromycin treatment for stable cell-line generation. Cell line validation included immunofluorescence with markers appropriate for the cell population of interest. RNA sequencing of cell lines was compared to ACP transcriptome reference data. Cell typing was conducted using short tandem repeat sequencing. RESULTS: ACP fibroblasts and ACP epithelial cells maintained spindle-like and cobblestone morphologies respectively, even after 4 passages. Immunofluorescence staining confirmed high levels of Vimentin expression in ACP-derived fibroblasts, and panCK and B-catenin in ACP-derived epithelial cells. Point mutation in exon 3 of the CTNNB1 gene was identified in ACP-derived epithelial cells. CONCLUSION: Initial limits related to cell line development in ACP may be addressed through the isolation and culture-specific ACP cell populations. This experience demonstrates the maintenance of validated markers of the cell populations of interest ex vivo. While preliminary, such cell lines offer promise as tools for the identification and study of potential therapeutic vulnerabilities in ACP.
format Online
Article
Text
id pubmed-9165211
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91652112022-06-05 RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response Trudeau, Tammy Prince, Eric Chatain, Oscar Chee, Keanu Jackson, Eric Limbrick, David Naftel, Robert Feldstein, Neil Grant, Gerald Ginn, Kevin Niazi, Toba Smith, Amy Kilburn, Lindsay Chern, Joshua Drapeau, Annie Lam, Sandi Johnston, James Dudley, Roy Staulcup, Susan Hankinson, Todd Neuro Oncol Craniopharyngioma and Rare Tumors BACKGROUND: Challenges around the design and investigation of cell culture models of adamantinomatous craniopharyngioma (ACP) have arisen from the cellular heterogeneity of these tumors, with populations that harbor disparate requirements in culture. Novel approaches to in vitro modeling of ACP are needed. METHODS: Intraoperatively collected tumor specimens were mechanically digested and plated under conditions tailored to the cell population of interest. ACP tumor-derived fibroblasts and epithelial cells were isolated using serum-containing and keratinocyte-specific media respectively. ACP-derived epithelial cells were immortalized via SV40 virus transfection and puromycin treatment for stable cell-line generation. Cell line validation included immunofluorescence with markers appropriate for the cell population of interest. RNA sequencing of cell lines was compared to ACP transcriptome reference data. Cell typing was conducted using short tandem repeat sequencing. RESULTS: ACP fibroblasts and ACP epithelial cells maintained spindle-like and cobblestone morphologies respectively, even after 4 passages. Immunofluorescence staining confirmed high levels of Vimentin expression in ACP-derived fibroblasts, and panCK and B-catenin in ACP-derived epithelial cells. Point mutation in exon 3 of the CTNNB1 gene was identified in ACP-derived epithelial cells. CONCLUSION: Initial limits related to cell line development in ACP may be addressed through the isolation and culture-specific ACP cell populations. This experience demonstrates the maintenance of validated markers of the cell populations of interest ex vivo. While preliminary, such cell lines offer promise as tools for the identification and study of potential therapeutic vulnerabilities in ACP. Oxford University Press 2022-06-03 /pmc/articles/PMC9165211/ http://dx.doi.org/10.1093/neuonc/noac079.049 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Craniopharyngioma and Rare Tumors
Trudeau, Tammy
Prince, Eric
Chatain, Oscar
Chee, Keanu
Jackson, Eric
Limbrick, David
Naftel, Robert
Feldstein, Neil
Grant, Gerald
Ginn, Kevin
Niazi, Toba
Smith, Amy
Kilburn, Lindsay
Chern, Joshua
Drapeau, Annie
Lam, Sandi
Johnston, James
Dudley, Roy
Staulcup, Susan
Hankinson, Todd
RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
title RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
title_full RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
title_fullStr RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
title_full_unstemmed RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
title_short RARE-24. The use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
title_sort rare-24. the use of novelin vitro models to study adamantinomatous craniopharyngioma disease biology and drug response
topic Craniopharyngioma and Rare Tumors
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165211/
http://dx.doi.org/10.1093/neuonc/noac079.049
work_keys_str_mv AT trudeautammy rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT princeeric rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT chatainoscar rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT cheekeanu rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT jacksoneric rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT limbrickdavid rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT naftelrobert rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT feldsteinneil rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT grantgerald rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT ginnkevin rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT niazitoba rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT smithamy rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT kilburnlindsay rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT chernjoshua rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT drapeauannie rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT lamsandi rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT johnstonjames rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT dudleyroy rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT staulcupsusan rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse
AT hankinsontodd rare24theuseofnovelinvitromodelstostudyadamantinomatouscraniopharyngiomadiseasebiologyanddrugresponse